mrnaveed

#ModernaRisesOver12% Moderna ($MRNA) Surges Over 12%, Hitting 52-Week Highs on Pipeline Breakthroughs 🚀
Moderna is proving there is life—and massive growth—well beyond COVID-19 vaccines. The stock surged over 12% on Friday, hitting a 52-week high of $67.78, fueled by a highly successful "Science Day" investor presentation.
Investors are rallying behind strong diversification milestones, including:
Unanimous FDA Advisory Support: A clean 9-0 vote favoring their investigational seasonal flu vaccine (mRNA-1010) ahead of its August PDUFA date.
Oncology Breakthroughs: Exciting pipeline updates regarding cancer antigen therapies (like mRNA-4194 for Lynch Syndrome).
Autoimmune Progress: Advancing the mRNA-6007 CAR-T program into early development for Lupus.
With Wall Street targets shifting upwards (Piper Sandler raised its target to $77), Moderna is successfully reshaping its narrative into a diversified mRNA powerhouse.
#Biotech #StockMarket #MrNaveed #Investing

#MrNaveed Btc